Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
<h4>Background</h4>Bangladesh is one of the endemic countries for Visceral Leishmaniasis (VL). Médecins Sans Frontières (MSF) ran a VL treatment clinic in the most endemic district (Fulbaria) between 2010 and 2013 using a semi-ambulatory regimen for primary VL of 15 mg/kg Liposomal Amphotericin-B (A...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2015-04-01
|
| シリーズ: | PLoS Neglected Tropical Diseases |
| オンライン・アクセス: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0003699&type=printable |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
